Inside Ahsoka Season 2: Plot, Trailer Hints & Thrawn’s Return
The galaxy is buzzing with anticipation—Ahsoka Season 2 is officially on the horizon! After the resounding success of the first season, fans are eager to dive back into the Star Wars universe with everyone’s favorite former Jedi, Ahsoka Tano. Whether you're curious about the
Ahsoka: A Quick Recap for Newcomers
Before diving into what's next, let’s quickly revisit where it all began. Ahsoka, a Disney+ original series, follows Ahsoka Tano, the beloved character first introduced in Star Wars: The Clone Wars
Season 1 captivated both new and longtime Star Wars fans by introducing live-action versions of Sabine Wren, Ezra Bridger, and Grand Admiral Thrawn. The show ended on a cliffhanger, with Ahsoka stranded in a distant galaxy—setting up massive stakes for Season 2.
Ahsoka Season 2 Release Date: When Is It Coming Out?
One of the most frequently searched questions is: When is Ahsoka Season 2 coming out?
As of mid-2025, Lucasfilm has confirmed that Ahsoka Season 2 is in development, but an official release date has not been announced. However, industry insiders speculate that the release will likely fall in late 2026 or early 2027, depending on filming schedules and post-production timelines.
Given the visual scale and heavy special effects, Ahsoka Season 2 will likely follow the release pattern of other Star Wars shows like The Mandalorian, which typically have 12–18 months between seasons.
Key takeaway: While there's no exact Ahsoka Season 2 release date yet, fans can expect updates toward the end of 2025.
Ahsoka Season 2 Trailer: Has It Dropped Yet?
Another hot topic is the potential for an Ahsoka Season 2 trailer. Unfortunately, as of now, there is no official trailer available. However, filming is rumored to be starting soon, meaning we might get a teaser trailer by mid-2026—perhaps revealed at
When the Ahsoka Season 2 trailer does drop, expect glimpses of intense lightsaber battles, mysterious Force lore, and perhaps more of the enigmatic Baylan Skoll storyline left hanging after Season 1.
Tip for fans: Keep your eyes on Disney+ and the official Star Wars YouTube channel for teaser announcements.
What to Expect in Ahsoka Season 2
A Deeper Dive into the Force
Season 1 introduced mystical elements like the World Between Worlds and ancient Force lore. In Season 2, showrunner Dave Filoni is expected to dig even deeper into these mystical aspects, especially with Ahsoka’s spiritual journey continuing in a new galaxy.
Thrawn’s Master Plan
Grand Admiral Thrawn, played by Lars Mikkelsen, is now a looming threat to the New Republic. Fans anticipate that Thrawn will start rallying forces, potentially tying directly into the upcoming Star Wars: Heir to the Empire film also being developed by Filoni.
Thrawn is not just a villain—he’s a master strategist. Season 2 will likely focus on the conflict between Thrawn’s return and the fragile peace established post-Empire.
Sabine and Ezra’s Role
The reunion between Sabine Wren and Ezra Bridger was one of Season 1’s most emotional payoffs. Season 2 is expected to further explore their bond and evolution. Sabine, who is now Force-sensitive, might undergo formal training under Ahsoka—or clash with her.
Ezra’s adjustment to returning to the known galaxy and what role he plays in resisting Thrawn will be another central thread.
Cast: Who’s Returning for Ahsoka Season 2?
While Disney has yet to announce the full cast of Ahsoka Season 2, here are the actors likely to return:
-
Rosario Dawson as Ahsoka Tano
-
Natasha Liu Bordizzo as Sabine Wren
-
Eman Esfandi as Ezra Bridger
-
Lars Mikkelsen as Grand Admiral Thrawn
-
Diana Lee Inosanto as Morgan Elsbeth (if flashbacks are involved)
A major question mark is the character of Baylan Skoll, originally portrayed by the late Ray Stevenson. Lucasfilm may choose to recast the role or write a new arc around it.
Will There Be a Crossover Event?
Ahsoka Season 2 may not be a standalone story. With Dave Filoni building a shared Star Wars timeline with The Mandalorian, The Book of Boba Fett
Ahsoka Season 2 Is the Future of Star Wars
Ahsoka Season 2 is shaping up to be a cornerstone of the live-action Star Wars universe. With new threats, deeper Force mythology, and beloved characters returning, it’s no surprise fans are eagerly awaiting every update.
While the Ahsoka Season 2 release date and trailer are still under wraps, the series continues to build buzz and excitement. Until then, fans can rewatch Season 1 on Disney+ and keep an eye on announcements from
Dad with deadly brain cancer that kills in a year is cancer free after taking new drug
A breakthrough drug is fighting brain cancer head-on.
Glioblastoma is widely considered the deadliest form of brain cancer, killing over 10,000 Americans each year. There is no cure for the highly aggressive disease — many patients survive just nine months after diagnosis.
Ben Trotman was diagnosed with glioblastoma in October 2022 at 40.
Treatment focuses on managing symptoms and extending life via surgery to remove as much of the tumor as possible and radiation therapy and chemotherapy to destroy cancer cells.
Now, researchers from University College London Hospitals are recruiting glioblastoma patients for a trial of the immunotherapy drug ipilimumab. Sold under the brand name Yervoy, the monoclonal antibody stimulates the immune system to recognize and attack cancer cells.
Oncologists are optimistic since a UK father shows no signs of having a tumor after he took ipilimumab before his glioblastoma treatment.
Ben Trotman was diagnosed with glioblastoma in October 2022 at 40.
“The crucial element of this trial is that patients will have their immune system boosted by the drug before they have any other treatment, when they are fit and well enough to tolerate the immunotherapy,” said Dr. Paul Mulholland, the consultant medical oncologist leading the trial.
“We saw with Ben, the one patient recruited to the immunotherapy study, NeAT-GLIO, that he has had clear scans since having the treatment and the tumor hasn’t returned more than two and a half years later.”
Glioblastoma is widely considered the deadliest form of brain cancer, killing over 10,000 Americans each year.
Trotman met with Mulholland, who enrolled him in a clinical trial for ipilimumab. He was the first patient in the world — and the only person in the trial — to take the drug before glioblastoma treatment.
“Getting this diagnosis was the most traumatic experience,” said Trotman’s wife, Emily.
“We were grappling with the fact that Ben had gone from being apparently perfectly healthy to having months to live.”
After taking the drug, Ben underwent radiotherapy and chemotherapy.
Two years and eight months later, his scans are clear.
“It is very unusual to have a clear scan with glioblastoma, especially when he didn’t have the follow-up surgery that had been planned to remove all of the tumor that was initially visible on scans,” Mulholland said.
Ben and Emily Trotman wed in 2023, after he began his immunotherapy treatment.
“We hope that the immunotherapy and follow-up treatment Ben has had will hold his tumor at bay,” he added, “and it has so far, which we are delighted to see.”
In January 2023, months after his diagnosis, Ben married Emily. The couple welcomed a daughter, Mabel, earlier this year.
They enjoy taking her for walks along with their rescue dog, Jerry.
“We are trying to live as normal a life as possible,” Emily said.
“We are in a unique position of which there is no precedent and which comes with a great deal of uncertainty,” she continued. “We want to live each day as if it were our last, but we also want to plan for the future, which we hope to have.”
Researchers plan to recruit 16 glioblastoma patients like Ben over 18 months.
After taking ipilimumab, the trial participants will undergo radiotherapy and chemotherapy and perhaps surgery depending on the extent of their disease.
Dr. Paul Mulholland and Dame Siobhain McDonagh, who raised funds for the new clinical trial of ipilimumab.
The trial is being funded by Dame Siobhain McDonagh, a member of the British Parliament, whose sister died of glioblastoma in 2023.
“My beloved sister Margaret was appalled to discover that there had been no advances in brain cancer treatment for decades when she was diagnosed with glioblastoma,” McDonagh said. “Changing this was Margaret’s final campaign and one that I have continued in her memory.”
Treatment will take place at the NIHR UCLH’s Clinical Research Facility at the National Hospital for Neurology and Neurosurgery.
“I am delighted that this new trial, with the same immunotherapy drug I received, is going ahead and others will have the opportunity to take part,” Ben said. “It will give people newly diagnosed with glioblastoma some hope.”
